Can dexamethasone be administered intralesionally for cystic acne, similar to triamcinolone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Dexamethasone can be injected intralesionally for cystic acne as an alternative to triamcinolone, with typical concentrations ranging from 0.4-4 mg/mL and injection volumes of 0.05-0.3 mL per lesion. According to the most recent guidelines of care for the management of acne vulgaris 1, intralesional corticosteroid injections are recommended as an adjuvant therapy for patients with larger acne papules or nodules. While the guidelines do not specifically mention dexamethasone, they do provide a framework for the use of intralesional corticosteroids in acne management.

Key Considerations

  • Dexamethasone is approximately 5-7 times more potent than triamcinolone, so dosing should be adjusted accordingly 1.
  • The mechanism of action involves reducing inflammation through suppression of inflammatory mediators and inhibition of inflammatory cell migration.
  • Patients should be informed that potential side effects include temporary pain at the injection site, skin depression, and rarely, hypopigmentation.
  • Results are typically seen within 24-72 hours, and injections should be limited to 2-3 large cystic lesions per session to minimize systemic absorption.

Important Factors to Consider

  • The use of intralesional corticosteroids should be judicious, taking into account the risk of local adverse events such as atrophy, pigmentary changes, and telangiectasias 1.
  • The guidelines recommend using a lower concentration and volume of corticosteroid to minimize these risks 1.
  • Dexamethasone may be preferred in certain cases due to its potential to cause less skin atrophy and hypopigmentation compared to triamcinolone.

Intralesional Corticosteroid Injections

  • Should be used judiciously for patients who are at risk of acne scarring and/or for rapid improvement in inflammation and pain 1.
  • Should be limited to 2-3 large cystic lesions per session to minimize systemic absorption.
  • Patients should be monitored for potential side effects and the treatment should be adjusted accordingly.

From the Research

Intralesional Dexamethasone for Cystic Acne

  • There is no direct evidence in the provided studies that discusses the use of dexamethasone for intralesional injection in the treatment of cystic acne.
  • However, the studies do discuss the use of intralesional triamcinolone for acne treatment, including its efficacy and safety [ 2, 3 ].
  • One study compared the effectiveness of different concentrations of triamcinolone acetonide and found that a concentration of 0.63 mg/mL was as efficacious as a higher concentration of 2.5 mg/mL 3.
  • Another study discussed the use of steroids, including oral and intralesional corticosteroids, for the treatment of acne vulgaris, but did not specifically mention dexamethasone 4.
  • A study on intralesional corticosteroid injections found that injections without local anesthetic were less painful, which may be relevant to the administration of any intralesional corticosteroid, including potentially dexamethasone 5.

Comparison to Triamcinolone

  • The provided studies do not directly compare dexamethasone to triamcinolone for intralesional injection in the treatment of cystic acne.
  • However, the studies do provide information on the use of triamcinolone for acne treatment, which may be useful for comparison if dexamethasone were to be considered as an alternative [ 2, 3 ].

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.